Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nightstar nets $80.3mm in US IPO

Executive Summary

Ophthalmic-focused Nightstar Therapeutics Ltd. (formerly NightstaRx) netted $80.3mm through its initial public offering of 6.16mm American Depositary Shares (including full exercise of the overallotment) priced at $14mm (the middle of its intended $13-15 range) on the Nasdaq. Each ADS represents one ordinary share.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies